期刊文献+

芳维A酸氨丁三醇对HaCaT细胞环氧化酶-2 mRNA表达的影响

The influence of FY-10 on the cyclooxygenase-2 mRNA expression of HaCaT cell
暂未订购
导出
摘要 目的:观察第三代维A酸药物芳维A酸氨丁三醇(代号FY-10)对人角质形成细胞环氧化酶-2表达的影响。方法:通过体外培养HaCaT细胞,脂多糖(LPS)诱导环氧化酶-2(COX-2)mRNA表达,再以芳维A酸氨丁三醇处理细胞后,采用RT-PCR的方法检测COX-2表达水平的变化。结果:(1)以10μg/L终浓度LPS作用细胞2h后,细胞COX-2 mRNA表达明显高于作用前(x-±s分别为0.779±0.099和1.033±0.207,t值为6.083,P=0.00012)。(2)在加入LPS的同时加入芳维A酸氨丁三醇可以明显降低COX-2 mRNA的表达,二者的x-±s分别为1.161±0.130和0.849±0.056,(t值为5.398,P<0.01)。(3)芳维A酸氨丁三醇的作用呈浓度依赖性,以1×10-6mol/L作用最强。结论:芳维A酸氨丁三醇对人角质形成细胞的环氧化酶-2有肯定的抑制作用,为其治疗以炎症细胞浸润为表现的银屑病提供了理论基础。 Objective: To detennine the effect of the retinoic acid (FY- 10) on the expression of cyclooxygenase 2 (COX- 2) of human keratinocytes (HaCaT cell line). Methods: Lipopolysaccharide(LPS) inducing COX- 2 mRNA expression in vitro cultured human epidermal keratinocyte was determined by reverse transcriptase polymerase chain reaction (RT- PCR) before and after treatment with FY- 10. Results: (1)The expression of COX- 2 was significantly increased after HaCaT cell was treated with LPS 10 ug/L final concentration for 2 hours or longer. (2) FY- 10 distinctly depressed the expression of COX- 2 induced by LPS. (3)The effect of FY- 10 was concentrat ion dependent, which was strongest in a concentration of 1 × 10^-6 mol/L. Conclusion: FY- 10 can definitely depress the expression of cyclooxygenase 2 in HaCaT cell line, which provides a base for the treatment of psoriasis characterized by infiltration of inflammatory cells.
出处 《中国麻风皮肤病杂志》 2007年第4期290-292,共3页 China Journal of Leprosy and Skin Diseases
关键词 银屑病 维A酸 环氧化酶 芳维A酸氨丁三醇 角质形成细胞 psoriasis retinoic acid cyclooxygenase
  • 相关文献

参考文献7

二级参考文献13

  • 1张建中,马圣清,丸山幸治,金子史男.1,25-双羟维生素D_3和MC903对培养人角朊细胞白介素1α及白介素8分泌的影响[J].中华皮肤科杂志,1996,29(2):93-95. 被引量:15
  • 2张建中,中华皮肤科杂志,1996年,29卷,27页
  • 3Stuart LS,Gerald RC.The mechanism of action of cyclosporin A and FK506[].Immunology Today.1992
  • 4Carl N,Qiao Wen X.Nitric Oxide Synthases: Roles, Tolls, and Controls[].Cell.1994
  • 5Roderick CM,Richard W.Langerhans cells, keratinocytes, nitric oxide and psoriasis[].Immunology Today.1998
  • 6Lemster BH,Carroll PB,Rilo HR,et al.IL-8/IL-8 receptor expression in psoriasis and the response to systemic tacrolimus(FK506) therapy[].Clinical and Experimental Immunology.1995
  • 7Lewis HM.Therapeutic progress II: treatment of psoriasis[].Journal of Clinical Pharmacy and Therapeutics.1994
  • 8Daniela BC,Karin F,Christoph S,et al.A Proinflammatory Activity of Interleukin 8 in Human Shin: Expression of the Inducible Nitric Oxide Synthase in Psoriatic Lesions and Cultured Keratinocytes[].The Journal of Experimental Medicine.1996
  • 9Green LC,Wagner DA,Glogowski J,et al.Analysis of nitrate,and [15N] nitrate in biologial fluids[].Analytical Biochemistry.1982
  • 10Ockenfels HM,Schultewolter T,Ockenfels G,et al.The antipsoriatic agent dimethylfuma-rate immnomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network[].Br J Dermatol.1998

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部